[Ceftazidime in the therapy of chronic bronchitis relapses in elderly hospitalized patients].
We studied the clinical and bacteriological efficacy and the safety of ceftazidime in elderly patients suffering from recurrent chronic bronchitis. 33 hospitalized subjects (10 F. 23 M: mean age 78.5 +/- 6 yrs) were treated with ceftazidime (1 g b.i.d.) for a mean of 9 +/- 1.5 days. At the end of treatment all patients had positive clinical results, with bacteriological eradication equal to 95%. Only one case of relapse was observed at the follow up assessment. As to safety only one case of vomiting was observed (but did not require treatment withdrawal).
Vozza
A
A
III Divisione di Geriatria, Ospedale Maggiore, Verona.
Crivellaro
R
R
Panebianco
R
R
D000368:Aged; D000369:Aged, 80 and over; D001991:Bronchitis / Q000188:drug therapy* / Q000382:microbiology; D002442:Ceftazidime / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D012008:Recurrence
D002442:Ceftazidime
Il ceftazidime nella terapia delle riacutizzazioni di bronchite cronica in pazienti anziani ospedalizzati.